ApoB no better than current lipid markers in CVD risk prediction By Sally Robertson, medwireNews Reporter Assessment of apolipoprotein B levels does not seem to improve cardiovascular disease risk prediction over low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol, report researchers. ‘It appears realistic to continue to focus on the decrease in LDL cholesterol and non-HDL cholesterol levels for guiding the intensity of lipid-lowering therapy to decrease cardiovascular disease risk additional,’ say Jennifer Robinson and co-workers cialis generique 20mg tadalafilenfrance.com .

Other entries from category "tools":

Random entries